Siriraj Hospital

Futó vizsgálatok

• Még nem toboroz

  A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)

  NCT07915219· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  NCT07789015· 3. fázis· Boehringer Ingelheim· Forrás

• Még nem toboroz

  A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

  NCT07595042· 2. fázis· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Toboroz

  A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

  NCT07124559· 1/2. fázis· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Toboroz

  A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease

  NCT07298421· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Hypofractionated Chemoradiotherapy for Cervical Cancer

  NCT07709650· 3. fázis· Mahidol University· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

  NCT07400107· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

  NCT07415954· 2. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis

  NCT07158242· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

  NCT07472517· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

  NCT07355218· 3. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Toboroz

  A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07351058· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer

  NCT07595224· Siriraj Hospital· Forrás

• Toboroz

  A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia

  NCT07206472· Daiichi Sankyo· Forrás

• Toboroz

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás

• Meghívásos bevonás

  Use of Gender, Age, Alfa-fetoprotein (AFP), and Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score in Addition to Ultrasound for Surveillance of People At-risk for Developing Hepatocellular Carcinoma in Asia in Order to Detect Early Liver Cancer

  NCT07298577· Siriraj Hospital· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  NCT07216703· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

  NCT07078929· 1. fázis· Chulalongkorn University· Forrás

• Toboroz

  KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

  NCT07252739· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

  NCT06899126· 3. fázis· Daiichi Sankyo· Forrás

• Fut, nem toboroz

  A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)

  NCT07044297· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

  NCT06757634· 3. fázis· Celcuity Inc· Forrás

• Toboroz

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  NCT06966700· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

  NCT06872892· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

  NCT06952504· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

  NCT06806852· 1. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study

  NCT06937918· Mahidol University· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  NCT06824467· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· 3. fázis· Daiichi Sankyo· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis

  NCT06878404· 3. fázis· Janssen Research & Development, LLC· Forrás

• Meghívásos bevonás

  Frequency of Food Allergy Confirm by Oral Food Challenge Among Foods Avoidance in Atopic Dermatitis Children

  NCT06947252· Mahidol University· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

  NCT06807424· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  NCT06750094· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  Long-term Efficacy of Once Daily Versus Twice Daily Aspirin in High-risk MPN Patients With Aspirin Resistance

  NCT06740916· 3. fázis· Siriraj Hospital· Forrás

• Fut, nem toboroz

  A Phase 3 Study of NTLA-2001 in ATTRv-PN

  NCT06672237· 3. fázis· Intellia Therapeutics· Forrás

• Toboroz

  An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B

  NCT06700096· 3. fázis· Biocad· Forrás

• Fut, nem toboroz

  A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

  NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás

• Fut, nem toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

  NCT06497556· 3. fázis· Hoffmann-La Roche· Forrás

• Toboroz

  Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

  NCT06252649· 3. fázis· Amgen· Forrás

• Toboroz

  Diabetes-Centered Evaluation of Revascularization Strategy of Functional and Imaging-CombiNEd State-of-the-Art Percutaneous Coronary Intervention or Coronary-Artery Bypass Grafting in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease

  NCT05831085· Duk-Woo Park, MD· Forrás

• Fut, nem toboroz

  Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

  NCT06305754· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

  NCT06056297· 3. fázis· X4 Pharmaceuticals· Forrás

• Toboroz

  Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa

  NCT06242379· 1/2. fázis· Mahidol University· Forrás

• Fut, nem toboroz

  A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)

  NCT06356311· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Standard Care With or Without Early Palliative Care Provided by Palliative Care Specialist in Advanced Non-small Cell Lung Cancer Patients

  NCT06786468· Mahidol University· Forrás

• Toboroz

  Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

  NCT06170788· 3. fázis· Merck Sharp & Dohme LLC· Forrás

Showing 50 of 90.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák6 toboroz
• 2-es típusú cukorbetegség3 toboroz
• Koszorúér-betegség3 toboroz
• Méhnyakrák3 toboroz
• Stroke (szélütés)3 toboroz
• Tuberkulózis3 toboroz
• Dermatomyositis and polymyositis (myositis)2 toboroz
• Familiáris hiperkoleszterinémia2 toboroz
• Gyermekkori daganatok2 toboroz
• HIV-fertőzés2 toboroz
• Méhtestrák2 toboroz
• Peripheral artery disease2 toboroz
• Vastagbélrák2 toboroz
• Akut limfoid leukémia (ALL)1 toboroz
• Atópiás dermatitisz (ekcéma)1 toboroz
• Áttétes emlőrák1 toboroz
• Bronchiectasis1 toboroz
• Colitis ulcerosa1 toboroz
• Crohn-betegség1 toboroz
• Elhízás1 toboroz
• Gyomor- és nyelőcsőrák1 toboroz
• Hemofília1 toboroz
• Hepatitis B (krónikus)1 toboroz
• Hepatitis C1 toboroz
• Krónikus limfoid leukémia (CLL)1 toboroz
• Krónikus vesebetegség1 toboroz
• Liver cirrhosis1 toboroz
• Lupus (SLE)1 toboroz
• Magas vérnyomás1 toboroz
• Máj- és epeúti rák1 toboroz
• Mieloproliferatív neopláziák1 toboroz
• Petefészekrák1 toboroz
• Retinitis pigmentosa1 toboroz
• Szarkóma1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Tripla negatív emlőrák1 toboroz

Lezárt vizsgálatok

• Visszavonták

  A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes

  NCT07357740· 2. fázis· Novo Nordisk A/S· Forrás

• Visszavonták

  A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight

  NCT07357766· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease

  NCT06926660· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  The Effects of Hypoxic Burden on Executive Function (EF) in Preschool Children With Obstructive Sleep Apnea

  NCT07023458· Mahidol University· Forrás

• Lezárult

  A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

  NCT06664801· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

  NCT06465186· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

  NCT06131372· 2. fázis· Novo Nordisk A/S· Forrás

• Leállították

  Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis

  NCT05962788· 3. fázis· Aurinia Pharmaceuticals Inc.· Forrás

• Visszavonták

  Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes

  NCT06083675· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

  NCT06010303· 2. fázis· BeiGene· Forrás

• Leállították

  Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis

  NCT05288855· 3. fázis· Aurinia Pharmaceuticals Inc.· Forrás

• Lezárult

  A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma

  NCT05909904· 2. fázis· BeiGene· Forrás

• Lezárult

  A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma

  NCT05907122· 3. fázis· Amgen· Forrás

• Lezárult

  A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

  NCT05877547· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Leállították

  A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7565020 in Healthy Participants and in Participants With Chronic Hepatitis B Virus Infection

  NCT05763576· 1. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

  NCT05704738· 3. fázis· Amgen· Forrás

• Lezárult

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· 3. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

  NCT05586971· 3. fázis· LG Chem· Forrás

• Lezárult

  A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

  NCT05394519· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study of Ibrutinib With Rituximab in Relapsed or Refractory Mantle Cell Lymphoma

  NCT05564052· 2. fázis· Janssen Research & Development, LLC· Forrás

• Lezárult

  Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

  NCT05586958· 3. fázis· LG Chem· Forrás

• Lezárult

  A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

  NCT05523167· 2/3. fázis· argenx· Forrás

• Lezárult

  A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

  NCT05321069· 3. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

  NCT05406583· 1. fázis· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Lezárult

  Research Study Investigating How Well Semaglutide Works in People From Thailand and South Korea Living With Obesity

  NCT04998136· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)

  NCT05342636· 1/2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  The Effects of Vitamin D and Calcium Supplementation to Parathyroid Hormone in CHB Patients Treated With TDF

  NCT05313477· 4. fázis· Mahidol University· Forrás

• Lezárult

  Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

  NCT05052801· 3. fázis· Amgen· Forrás

• Lezárult

  Efficacy and Safety of Intrathecal OAV101 (AVXS-101) in Pediatric Patients With Type 2 Spinal Muscular Atrophy (SMA)

  NCT05089656· 3. fázis· Novartis Pharmaceuticals· Forrás

• Lezárult

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)

  NCT05144841· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A PMCF Study in Patients With Thoracoabdominal Aortic Aneurysms Treated With E-nside TAAA Multibranch Stent Graft System (INNER-B-APAC)

  NCT05954793· JOTEC GmbH· Forrás

• Lezárult

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

  NCT05013229· 3. fázis· Novo Nordisk A/S· Forrás

• Leállították

  Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

  NCT04518228· National Institute of Allergy and Infectious Diseases (NIAID)· Forrás

• Lezárult

  ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

  NCT05021835· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)

  NCT04891770· 2. fázis· Gilead Sciences· Forrás

• Leállították

  Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014).

  NCT04949256· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

  NCT04785820· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002)

  NCT04725188· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

  NCT04732494· 2. fázis· BeiGene· Forrás

• Lezárult

  A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma

  NCT04540211· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

  NCT04225715· 2. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)

  NCT04248829· 3. fázis· Yuhan Corporation· Forrás

• Lezárult

  A Study of Atezolizumab Plus Bevacizumab Versus Active Surveillance as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Surgical Resection or Ablation

  NCT04102098· 3. fázis· Hoffmann-La Roche· Forrás

• Lezárult

  Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

  NCT04003636· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

  NCT03940703· 2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Lezárult

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

  NCT03924856· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

  NCT03867084· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

  NCT03797326· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699

  NCT03606408· 2. fázis· RECORDATI GROUP· Forrás

Showing 50 of 56.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Obstructive sleep apnoea21 munka · 1 vizsgálat
• Thalassaemia15 munka · 2 vizsgálat
• Neuromyelitis optica (NMOSD)10 munka · 0 vizsgálat
• Hepatitis B (krónikus)9 munka · 6 vizsgálat
• Spinális izomatrófia (SMA)4 munka · 1 vizsgálat
• Immune thrombocytopenia (ITP)4 munka · 0 vizsgálat
• Charcot-Marie-Tooth disease3 munka · 0 vizsgálat